Botanical Holdings assessing a range of medical cannabis and CBD acquisitions

Carl Esprey from Botanical Holdings tells Proactive London’s Andrew Scott they’re looking at a multitude of investments across the legalised medical cannabis space and wellness CBD market.

”In terms of acquisitions we’re looking at everything from the plant, the growing and all the way to the consumer”

”’The strategy is to deliver an IPO this year and then focus on consistent capital returns to shareholders as well as paying a large dividend”.


Leave a Reply

Your email address will not be published. Required fields are marked *